CRO-related stocks are showing strong upward momentum in pre-noon trading, with notable gains across the sector.
As of the latest update, Genscript Bio (01548) has surged 16.28% to HK$37.86, leading the pack among the sector's performers.
Following closely behind, Biocytogen-B (02315) has climbed 6.14% to HK$62.20, while Viva Biotech (01873) is up 5.95% at HK$1.425.
Additionally, Asymchem Laboratories (06821) has advanced 3.28% to HK$169.90, contributing to the sector's broad-based rally during the morning session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments